Evaxion to Present New Preclinical Data for AI-Designed CMV Vaccine Candidate
Evaxion's EVX-V1 vaccine candidate uses an AI-driven, multi-antigen approach to target cytomegalovirus — a leading cause of congenital hearing loss.
Evaxion's EVX-V1 vaccine candidate uses an AI-driven, multi-antigen approach to target cytomegalovirus — a leading cause of congenital hearing loss.
Hearing care professionals can provide more comprehensive patient support and expand practice revenue by offering guidance on hearing technologies, ancillary products, and emerging treatment options beyond traditional hearing aids.
Findings from the state's mandated program demonstrate a decreased age at first audiology visit and increased detection of mild hearing loss in infants.
In this study, various audio and visual communication modalities were examined to identify which communication perspective could best benefit patients following a hearing aid fitting.
Frank Lin, MD, PhD, discusses the Know Your Hearing Number campaign and why this concept can help break down barriers to hearing care.
Developed by the National Acoustic Laboratories, the system builds on NAL-NL2 and is designed for more precise, personalized hearing aid fittings.
The FDA has approved an expanded indication for Med-El cochlear implants for children seven months and older with bilateral sensorineural hearing loss.